Hamilton Lane
HLNE
85.20
-1.30
-1.50%
Hamilton Lane
US · HLNE
#2333 by market cap
Listed 2017
85.20
-1.30
-1.50%
Live - 5344 symbols - heartbeat 221s ago
· 2026-10-08 07:35
Pre-market
85.20
0.00%
After-hours
85.20
0.00%
- Market cap
- 3.69B
- P/E (TTM)i
- 12.97
- P/Bi
- 3.93
- EPSi
- 5.92
- Div yieldi
- 2.61%
- 52W posi
- 17%
Reader sentiment
Are you bullish or bearish on HLNE?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.92, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +6.46% YoY
Margins
- Gross margin
- 69.88%
- Operating margin
- 42.81%
- Net margin
- 32.83%
Key ratios & quality
- PEG ratioi
- 0.41
- Altman Z-Scorei
- 3.92
PEG uses trailing P/E against the 3-year net income growth rate (31.69%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 252.18M | 274.05M | 341.64M | 367.92M | 528.75M | 553.84M | 712.96M | 758.99M |
| Gross profit | 153.18M | 188.29M | 225.26M | 259.52M | 379.44M | 387.45M | 504.74M | 530.36M |
| Selling & admin expenses | 48.96M | 71.86M | 69.54M | 89.96M | 139.40M | 141.63M | 188.19M | 205.42M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 104.22M | 116.43M | 155.73M | 169.56M | 240.04M | 245.82M | 316.55M | 324.94M |
| Pretax profit | 129.56M | 140.74M | 193.20M | 313.68M | 242.61M | 281.66M | 362.28M | 462.92M |
| Tax | 30.56M | 13.97M | 24.42M | 66.42M | 55.43M | 54.45M | 48.51M | 75.20M |
| Net profit | 99.00M | 126.78M | 168.79M | 247.25M | 187.19M | 227.21M | 313.77M | 387.72M |
| Basic EPS | 1 | 2 | 3 | 4 | 3 | 4 | 5 | 6 |
| Diluted EPS | 1.40 | 2.15 | 2.81 | 3.98 | 3.01 | 3.69 | 5.41 | 5.92 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 197.97M | 175.96M | 190.88M | 198.59M | 193.57M | 275.33M |
| Gross profit | 133.25M | 122.44M | 135.15M | 137.70M | 135.07M | 192.00M |
| Selling & admin expenses | 49.22M | 45.47M | 55.43M | 51.70M | 52.82M | 65.53M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 84.03M | 76.98M | 79.72M | 86.01M | 82.25M | 126.47M |
| Pretax profit | 88.26M | 95.45M | 117.58M | 120.05M | 129.84M | 149.97M |
| Tax | 14.95M | 18.38M | 13.98M | 27.25M | 15.59M | 25.08M |
| Net profit | 73.31M | 77.07M | 103.60M | 92.80M | 114.25M | 124.88M |
| Basic EPS | 1 | 1 | 2 | 1 | 2 | 2 |
| Diluted EPS | 1.23 | 1.28 | 1.69 | 1.37 | 1.57 | 1.93 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 79.25M | 93.19M | 404.22M | 412.81M | 182.72M | 247.13M | 492.49M | 561.34M |
| Cash & ST investments | 49.36M | 50.12M | 87.34M | 72.17M | 111.75M | 114.63M | 277.27M | 363.90M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 360.59M | 473.53M | 1.14B | 1.29B | 1.14B | 1.27B | 1.69B | 2.30B |
| Total current liabilities | 95.01M | 114.78M | 225.02M | 223.43M | 210.03M | 247.37M | 293.16M | 346.23M |
| Short-term debt | -- | -- | -- | -- | -- | -- | -- | -- |
| Long-term debt | 70.95M | 74.52M | 163.18M | 171.33M | 213.53M | 196.16M | 290.30M | 278.42M |
| Total liabilities | 190,869,000.00 | 236,128,000.00 | 546,318,000.00 | 557,460,000.00 | 566,351,000.00 | 595,242,000.00 | 766,460,000.00 | 838,357,000.00 |
| Total equity | 169.72M | 237.40M | 590.20M | 737.49M | 574.19M | 675.96M | 923.90M | 1.47B |
| Retained earnings | 17.69M | 47.09M | 87.51M | 185.15M | 243.82M | 316.70M | 455.51M | 614.69M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 492.49M | 510.89M | 515.30M | 567.55M | 561.34M | 612.44M |
| Cash & ST investments | 277.27M | 315.88M | 326.56M | 340.19M | 363.90M | 341.72M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 1.69B | 1.80B | 1.98B | 2.17B | 2.30B | 2.54B |
| Total current liabilities | 293.16M | 318.42M | 314.46M | 318.23M | 346.23M | 307.39M |
| Short-term debt | -- | -- | -- | -- | -- | -- |
| Long-term debt | 290.30M | 288.58M | 285.61M | 279.52M | 278.42M | 274.20M |
| Total liabilities | 766,460,000.00 | 806,992,000.00 | 822,270,000.00 | 844,762,000.00 | 838,357,000.00 | 846,626,000.00 |
| Total equity | 923.90M | 995.05M | 1.16B | 1.33B | 1.47B | 1.69B |
| Retained earnings | 455.51M | 486.91M | 535.24M | 571.04M | 614.69M | 670.46M |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 111.62M | 116.37M | 188.16M | 169.52M | 226.59M | 120.85M | 300.82M | 424.92M |
| Depreciation & amortization | 2.98M | 3.29M | 4.13M | 5.50M | 7.44M | 8.19M | 9.29M | 9.88M |
| Free cash flow | 106.26M | 110.22M | 168.52M | 161.00M | 221.84M | 109.78M | 288.66M | 419.07M |
| Dividends paid | -69.33M | -76.44M | -74.04M | -97.34M | -135.85M | -109.28M | -119.80M | -141.84M |
| Stock buybacks / issuance | 188.12M | 141.24M | 743.32M | 70.35M | -236.84M | 198.16M | 242.93M | 30.89M |
| Ending cash balance | 51.59M | 53.21M | 90.38M | 76.20M | 116.55M | 119.62M | 283.60M | 371.90M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 39.28M | 128.93M | 118.90M | 74.11M | 102.97M | 77.15M |
| Depreciation & amortization | 2.22M | 2.53M | 2.52M | 2.43M | 2.40M | 2.53M |
| Free cash flow | 35.84M | 127.59M | 117.81M | 72.45M | 101.23M | 75.35M |
| Dividends paid | -26.96M | -36.26M | -39.51M | -32.89M | -33.18M | -38.01M |
| Stock buybacks / issuance | 243.92M | -7.00K | 54.65M | -595.00K | -23.16M | -50.62M |
| Ending cash balance | 283.60M | 322.14M | 334.35M | 347.98M | 371.90M | 349.73M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 35.59 | 45.90 | 49.89 | 50.23 | 29.63 | 29.95 | 35.00 | 30.53 |
| ROA %i | 10.26 | 14.58 | 12.18 | 12.09 | 9.27 | 11.68 | 14.68 | 12.47 |
| ROIC %i | 20.77 | 29.82 | 27.58 | 27.89 | 17.68 | 18.80 | 23.54 | 21.26 |
| 5-year avg ROE %i | -- | -- | -- | 40.86 | 41.78 | 40.65 | 38.47 | 35.07 |
| EBIT margin %i | 52.58 | 52.39 | 57.28 | 86.52 | 47.51 | 52.87 | 52.68 | 62.96 |
| FCF / sales %i | 42.14 | 40.22 | 49.33 | 43.76 | 41.96 | 19.82 | 40.49 | 55.21 |
| Current ratioi | 0.83 | 0.81 | 1.80 | 1.85 | 0.87 | 1.00 | 1.68 | 1.62 |
| Quick ratioi | 0.76 | 0.72 | 0.53 | 0.56 | 0.80 | 0.93 | 1.62 | 1.56 |
| Debt / assetsi | 19.68 | 17.89 | 20.98 | 19.58 | 25.63 | 21.65 | 21.79 | 15.47 |
| LT debt / equityi | 64.37 | 54.72 | 100.14 | 73.10 | 70.37 | 52.40 | 51.35 | 38.95 |
| Interest coveragei | 43.63 | 50.98 | 78.19 | 68.63 | 29.15 | 26.20 | 28.17 | 31.96 |
| Revenue CAGR (3Y) %i | 11.73 | 15.08 | 11.87 | 13.42 | 24.49 | 17.47 | 24.67 | 12.81 |
| Net income CAGR (3Y) %i | -- | 363.21 | 78.14 | 63.22 | 21.51 | 12.85 | 14.20 | 31.69 |
| FCF CAGR (3Y) %i | -0.62 | 11.09 | 21.29 | 14.86 | 26.26 | -13.31 | 21.49 | 23.62 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 35.00 | 32.03 | 31.85 | 30.59 | 30.53 | 32.49 |
| ROA %i | 14.68 | 13.37 | 13.40 | 12.41 | 12.47 | 12.71 |
| ROIC %i | 23.54 | 21.94 | 22.34 | 20.87 | 21.26 | 22.74 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 52.68 | 52.76 | 55.49 | 57.18 | 62.96 | 61.98 |
| FCF / sales %i | 40.49 | 48.83 | 46.38 | 46.33 | 55.21 | 42.74 |
| Current ratioi | 1.68 | 1.60 | 1.64 | 1.78 | 1.62 | 1.99 |
| Quick ratioi | 1.62 | 1.55 | 1.56 | 1.72 | 1.56 | 1.93 |
| Debt / assetsi | 21.79 | 20.28 | 18.24 | 16.58 | 15.47 | 14.37 |
| LT debt / equityi | 51.35 | 48.17 | 43.73 | 41.01 | 38.95 | 38.84 |
| Interest coveragei | 28.17 | 25.64 | 26.47 | 28.74 | 31.96 | 36.46 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Specialized funds is the largest reported line at 78.59% of revenue, across 6 reported segments.
- The next-largest line, Customized separate accounts, is a distant second at 14.93% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Specialized funds78.59%
Customized separate accounts14.93%
Reporting, monitoring, data and analytics3.60%
Advisory1.65%
Fund reimbursement revenue1.14%
Quote time 2026-10-08 07:35:34 · For reference only, not investment advice and not tailored to your situation.